• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

September 7, 2023

Obesity-Related Cardiovascular Disease Deaths Tripled in US From 1999 to 2020

Author(s):

Ashley Gallagher, Editor

Black women had the highest rates of obesity-related cardiovascular disease deaths whereas other racial groups had more men experiencing obesity-related CVD deaths than women.

Between 1999 and 2020, there was a 3-fold increase in obesity-related deaths associated with cardiovascular disease (CVD) in the United States, according to a new study published in the Journal of the American Heart Association.1

Stethoscope, red heart and cardiogram on gray table. Cardiology concept | Image Credit: New Africa - stock.adobe.com

New Africa - stock.adobe.com

In 2020, coronary heart disease was the leading cause of deaths at 41.2%, which was attributed to CVD in the United States, followed by stroke at 17.3%, other CVD at 16.8%, high blood pressure at 12.9%, heart failure at 9.2%, and diseases of the arteries at 2.6%. Additionally, CVD accounted for approximately 19.05 million global deaths in 2020, according to the American Heart Association’s 2023 statistics.2

“The number of [individuals] with obesity is rising in every country across the world. Our study is the first to demonstrate that this increasing burden of obesity is translating into rising heart disease deaths,” Zahra Raisi-Estabragh, MD, a clinical lecturer at the William Harvey Research Institute in London, said in a statement. “This rising trend of obesity is affecting some populations more than others, particularly Black women.”1

In the study, investigators analyzed the race, gender, and environmental settings to determine the differences in CVD deaths where obesity was listed as a contributing factor.1

Data were collected from The Multiple Cause of Death database from 1999 to 2020 on 281,135 deaths for which obesity was the contributing factor, including mortality and population counts from all US counties. Among the deaths, 4.3% were women, 78.1% were White, 19.8% were Black, 1.1% were Asian or Pacific Islander, and 1% were American Indian or Alaskan Native.1

In the study, ischemic heart disease was the most common primary cause of death, with the second being hypertensive disease, which was also the most common cause of death for Black individuals at 31%.3

Investigators found that obesity-related CVD deaths tripled from 2.2 per 100,000 population to 6.6 per 100,000 population between 1999 and 2020. Additionally, deaths were higher among Black individuals compared to any other racial groups at 6.7 per 100,000 population.1

Black women were observed to have the highest rates of obesity-related CVD deaths than in other studies whereas other racial groups had more men experiencing obesity-related CVD deaths than women.1 Furthermore, investigators found that Black adults in urban areas had higher rates of obesity-related CVD deaths compared to Black adults living in rural areas.1

Investigators added that these data were important to understand the racial disparities, noting that Black individuals in urban communities may be impacted more by socioeconomic deprivation and health inequities than Black individuals in rural areas.They also noted that Black individuals in urban areas did not seem to have the same benefits as other racial groups in urban areas.1

Investigators said that the data are limited as they represent the US population, so the results might not be applicable to our regions outside of the United States.3

References

  1. Obesity-related cardiovascular disease deaths tripled between 1999 and 2020. News release. American Heart Association. September 6, 2023. Accessed September 6, 2023. https://newsroom.heart.org/news/obesity-related-cardiovascular-disease-deaths-tripled-between-1999-and-2020?preview=9fc9
  2. Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association Circulation. 2023. doi:10.1161/CIR.0000000000001123
  3. Raisi-Estabragh Z, Kobo O, Mieres JH, et al. Racial disparities in obesity-related cardiovascular mortality in the United States: temporal trends from 1999 to 2020. J Am Heart Assoc. 2023;e028409. doi:10.1161/JAHA.122.028409
Related Videos
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Related Content
Advertisement
Skincare foam -- Image credit: Pavel | stock.adobe.com
Published: May 22nd 2025 | Updated: May 22nd 2025

FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children

Gillian McGovern, Associate Editor
Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial
May 20th 2025

Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Doctor with human Eye anatomy model with magnifying glass. Eye disease, Refractive Errors, Age Related Macular Degeneration, Cataract, Diabetic Retinopathy, Glaucoma, Amblyopia, Strabismus and Healt - Image credit: Jo Panuwat D | stock.adobe.com
May 22nd 2025

FDA Approves Ranibizumab Injection for Treatment of Diabetic Retinopathy

Kennedy Ferruggia, Assistant Editor
pharmacy focus oncology podcast
May 19th 2025

Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care

Alexandra Gerlach, Associate Editor
Adalimumab Medical Injection - Image credit: luchschenF | stock.adobe.com
May 22nd 2025

FDA Grants Interchangeability Designation to Yuflyma, Biosimilar for Humira Across All Approved Doses

Kennedy Ferruggia, Assistant Editor
3D visualization of natural killer cells | Image Credit: © N0X - stock.adobe.com
May 22nd 2025

Distinct NK Cell Subset Predicts Ibrutinib Response and Immune Pathway Activation in CLL

Alexandra Gerlach, Associate Editor
Related Content
Advertisement
Skincare foam -- Image credit: Pavel | stock.adobe.com
Published: May 22nd 2025 | Updated: May 22nd 2025

FDA Approves Roflumilast Topical Foam 0.3% for Plaque Psoriasis in Adults and Children

Gillian McGovern, Associate Editor
Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial
May 20th 2025

Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Doctor with human Eye anatomy model with magnifying glass. Eye disease, Refractive Errors, Age Related Macular Degeneration, Cataract, Diabetic Retinopathy, Glaucoma, Amblyopia, Strabismus and Healt - Image credit: Jo Panuwat D | stock.adobe.com
May 22nd 2025

FDA Approves Ranibizumab Injection for Treatment of Diabetic Retinopathy

Kennedy Ferruggia, Assistant Editor
pharmacy focus oncology podcast
May 19th 2025

Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care

Alexandra Gerlach, Associate Editor
Adalimumab Medical Injection - Image credit: luchschenF | stock.adobe.com
May 22nd 2025

FDA Grants Interchangeability Designation to Yuflyma, Biosimilar for Humira Across All Approved Doses

Kennedy Ferruggia, Assistant Editor
3D visualization of natural killer cells | Image Credit: © N0X - stock.adobe.com
May 22nd 2025

Distinct NK Cell Subset Predicts Ibrutinib Response and Immune Pathway Activation in CLL

Alexandra Gerlach, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.